Oncology Clinical Trials in Augusta, GA

As of September 2026, 43 paid clinical trials are recruiting for Oncology in Augusta, Georgia. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: September 1, 2026.

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

43 clinical trials for Oncology

·Clear filters·

Email me when a new oncology trial opens in Augusta, GA.

Pembrolizumab and Lenvatinib in Advanced Cervical Cancer

for Cervical Cancer

Sites in Augusta +2 more locations

Sponsor: Georgetown University

Sex: Female·Age: 18+

Code: NCT04865887·Phase 2·Recruiting·Listed Apr 2021

Apply to this trial

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

for Endometrial Cancer

Drug: Rilvegostomig

Sites in Augusta +47 more locations

Sponsor: AstraZeneca

Sex: Female·Age: 18+

Code: NCT06989112·Phase 3·Recruiting·Listed May 2025

Apply to this trial

A Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid Tumors

for Solid Tumor

Sites in Augusta +16 more locations

Sponsor: Biohaven Therapeutics Ltd.

Sex: All·Age: 18+

Code: NCT06384807·Phase 1, Phase 2·Recruiting·Listed Apr 2024

Apply to this trial

Oncology Clinical Trials in Augusta, GA

43 clinical trials for Oncology

Pembrolizumab and Lenvatinib in Advanced Cervical Cancer

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

A Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid Tumors

Conditions in Oncology (Augusta, GA)